Results 91 to 100 of about 22,384 (225)

The neurobiology of narcolepsy [PDF]

open access: yesTrends in Neurosciences, 1991
Narcolepsy is characterized by excessive sleepiness and abnormal manifestations of rapid eye movement (REM) sleep. Neurochemical studies of human and canine narcolepsy have demonstrated disturbed monoaminergic and cholinergic function and suggest that deficits of noradrenaline availability in specific brain regions may account for much of its ...
openaire   +3 more sources

Healthcare Burden and Productivity Loss Due to Narcolepsy in Sweden

open access: yesClocks & Sleep
Background: Narcolepsy impacts both patients and society, yet there is limited data on its socioeconomic consequences. Methods: This retrospective longitudinal cohort study used pseudonymized patient-level data from Swedish registers and included ...
Anna Giertz   +5 more
doaj   +1 more source

Cyclic hypersomnolence with symptoms of narcolepsy with cataplexy: An unusual presentation of probable immune-mediated encephalitis

open access: yeseNeurologicalSci, 2018
We report a case of probable encephalitis presenting as narcolepsy with cataplexy, but with cyclical exacerbation and cognitive difficulties. Our patient continued to worsen despite treatment for narcolepsy and later was thought to have an immune ...
Rafer Willenberg, Jonathan D. Bui
doaj   +1 more source

Sleep health of adults with cerebral palsy: A systematic review

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 12, Page 1645-1656, December 2026.
Although many people with cerebral palsy (CP) are adults, most sleep research in CP focuses on children. As poor sleep can affect pain, mood, energy, daily functioning, and quality of life we reviewed what is currently known about the sleep health of adults with CP. We searched three major research databases (MEDLINE, Embase, and CINAHL) up to February
Deepika Nagabhushan   +7 more
wiley   +1 more source

Knowledge Gaps in the Perioperative Management of Adults With Narcolepsy

open access: yes, 2019
International audienceThere is increasing awareness that sleep disorders may be associated with increased perioperative risk. The Society of Anesthesia and Sleep Medicine created the Narcolepsy Perioperative Task Force: (1) to investigate the current ...
Rahul Kakkar   +19 more
core   +1 more source

Exploring the Development of Vaccine Platforms, With a Particular Focus on the COVID‐19 Pandemic

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2421-2426, November 2026.
ABSTRACT Vaccines have been a cornerstone of human health for more than 200 years and one of the most important tools to reduce childhood deaths caused by pathogens. The concept of vaccines is basically to take something safe, make it immunogenic and induce an immune response in the host that will protect it against something dangerous. Live attenuated
Matti Sällberg
wiley   +1 more source

Psychological wellbeing and cognition in narcolepsy [PDF]

open access: yes
Background: Research has highlighted that people with narcolepsy experience diminished quality of life and psychosocial difficulties. Despite this, research has generally focused on type 1 narcolepsy, with minimal research investigating type 2 narcolepsy
Ng, C.
core  

Recent advances in narcolepsy

open access: yes, 2016
Narcolepsy is thought to affect 0.05% of Caucasian populations and frequently causes severe symptoms across the 24-hour period. It is best viewed as a disorder of sleep-wake regulation with particular abnormalities of the rapid eye movement (REM ...
Paul Reading
core   +1 more source

Plant‐Based Production of Human Major Histocompatibility Complex Class II Molecules

open access: yesPlant Biotechnology Journal, Volume 24, Issue 11, Page 5616-5630, November 2026.
ABSTRACT Major histocompatibility complex class II (MHC II) protein triggers adaptive immune responses by presenting antigens on antigen‐presenting cells (APCs) to be recognised by CD4+ T cells. Recombinant MHC II proteins are effective for the analysis of peptide‐binding interaction, detection of antigen‐specific T‐cells and clinical testing for donor‐
Abdelaziz Ramadan   +8 more
wiley   +1 more source

In Silico to In Cerebro—Development of the Orexin Receptor Antagonist “Photorexant” for Photomodulation In Vitro and in Mouse Brains

open access: yesAngewandte Chemie International Edition, Volume 65, Issue 42, 12 October 2026.
Following a structure‐based design approach, photoswitchable derivatives of the FDA‐approved drug suvorexant were designed, docked, synthesized, and characterized pharmacologically at the orexin 1 and 2 receptors (OX1R and OX2R). Optimized “photorexant” showed up to an 11‐fold difference in IC50 between photoisomers, enabled dynamic and reversible ...
Marcus Angermann   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy